Answers are grounded in this paper and cite their sources.
, in addition to distinguishing between blood serum samples from patients with different concentrations of CA19-9. Furthermore, by treating the capacitance data with information visualization methods, we were able to verify the selectivity and robustness of the immunosensor with regard to false positives, as the samples containing higher CA19-9 concentrations, including those from tumor cells, could be distinguished from those with possible interferents.
No takes yet. Share an insight, caveat, or question.
Soares et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: